Table_1_Oral microbiome correlates with selected clinical biomarkers in individuals with no significant systemic disease.xlsx حسب Mi Young Lim (4527712)

"…Compositional variation in the oral microbiome was significantly explained by four markers: fasting glucose, fasting insulin, white blood cell count, and total leukocyte count. …"

Clinical significance of non-thyroidal illness syndrome on disease activity and dyslipidemia in patients with SLE - Fig 4 حسب Xin Zhang (35492)

Clinical significance of non-thyroidal illness syndrome on disease activity and dyslipidemia in patients with SLE - Fig 2 حسب Xin Zhang (35492)

Clinical significance of non-thyroidal illness syndrome on disease activity and dyslipidemia in patients with SLE - Fig 3 حسب Xin Zhang (35492)

Clinical significance of non-thyroidal illness syndrome on disease activity and dyslipidemia in patients with SLE - Fig 1 حسب Xin Zhang (35492)

Significant relationships between exploratory proteins and measures of clinical severity. حسب Alexander J. Lowe (9248493)

"…<p>Correlation analysis between analyte concentration and composite Unified Huntington’s Disease Rating Scale (cUHDRS), Total Functional Capacity (TFC) and Total Motor Score (TMS) revealed significant associations between all three analytes and measures of clinical severity. …"

Mean hemoglobin levels of Roxadustat and ESAs groups over time. حسب Jie Liu (15128)

الموضوعات:

Clinical features of Parkinson’s disease. حسب Lexy Sorrell (15266813)

الموضوعات:

Adjusted odds ratios of ELC for significant clinical variables in bivariate analysis. حسب Laura Sánchez-Cirera (11840877)

Demographic and clinical characteristics in participants with and without significant coronary artery calcium. حسب Grace Lui (538705)

Data_Sheet_1_Efficient Assay and Marker Significance of NAD+ in Human Blood.pdf حسب Natalia V. Balashova (12564634)

"…In patients with demyelinating neurological diseases (n = 10, 18–55 years old), the NAD⁺ levels significantly (p < 0.0001) decrease (to 14 μM, min 13, max 16), compared to the control group. …"

Results for the time from infection to hospitalisation, segmented by symptom onset date. حسب Thomas Ward (688068)

الموضوعات:

Category B results and lognormal.stan program listing. حسب Thomas Ward (688068)

الموضوعات:

Results for the time from infection to hospitalisation by sex and age. حسب Thomas Ward (688068)

الموضوعات:

Results for the time from infection to death, segmented by symptom onset date. حسب Thomas Ward (688068)

الموضوعات:

Events O, A and B for the three time delay quantities. حسب Thomas Ward (688068)

الموضوعات:

Results for the time from infection to death by sex and age. حسب Thomas Ward (688068)

الموضوعات:

Results for the time from hospitalisation to death by sex and age. حسب Thomas Ward (688068)

الموضوعات:

Results for the time from hospitalisation to death, segmented by hospitalisation date. حسب Thomas Ward (688068)

الموضوعات:

Clinical characteristics of the study population. حسب Sergio R. Thomaz (20308465)

الموضوعات: